While Ventyx’s data “technically missed” by showing no effect on obesity, Wall Street analysts did not have high expectations for the medicine on that front, according to Jefferies analyst Andrew Tsai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback